Globus Medical’s board of directors authorized a share repurchase program of up to $500 million of the company’s outstanding common stock. Timing and number of repurchased shares will be determined by ...

Globus Medical (NYSE:GMED) announced that its board of directors authorized a share repurchase program totaling up to $500 ...

Looking back on medical devices & supplies - specialty stocks’ Q1 earnings, we examine this quarter’s best and worst ...

Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that its Board of Directors ...

Globus Medical (GMED) is down more than -19% after reporting Q1 net sales of $598.1 million, well below the consensus of $627.2 million, and forecast full-year adjusted EPS of $3.00-$3.30, weaker than ...

A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response ...

Globus Medical (GMED) closed down more than -22% after reporting Q1 net sales of $598.1 million, well below the consensus of $627.2 million, and forecast full-year adjusted EPS of $3.00-$3.30, weaker ...

Globus Medical, Inc. (NYSE: GMED) has announced its financial results for the first quarter of 2025, reporting revenue of ...